| 摘要: |
| 动脉粥样硬化是心脑血管疾病的独立危险因素，动脉硬化前期病变是动脉粥样硬化的亚临床阶段，在血浊理论的指导下干预治疗动脉粥样硬化前期病变，可降低急性心脑血管事件的发生率，也是中医治未病思想的体现，对于疾病的一级预防具有重大意义。 |
| 关键词: 血浊理论 动脉粥样硬化前期 治未病 清化血浊 |
| DOI：10.11656/j.issn.1672-1519.2021.12.11 |
| 分类号:R541.4 |
| 基金项目:王新陆全国名中医传承工作室（鲁财社指[2018]52号）；2021年山东省中医药高层次人才培育项目专项经费资助（鲁卫中医药科教字[2021]6号）；山东省医药卫生科技发展计划项目（2016WS0305）；青岛市医药科技发展计划项目（2020-WJZD044）。 |
|
| Research on syndrome differentiation and treatment of preclinical atherosclerosis of traditional Chinese medicine based on blood turbidity theory |
|
SUN Yingxin1, HAN Ping2, WANG Xinlu3
|
|
1.College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China;2.Qingdao Hospital of Traditional Chinese Medicine, Qingdao 266033, China;3.Shandong University of Traditional Chinese Medicine, Jinan 250355, China
|
| Abstract: |
| Atherosclerosis is an independent hazard factor for cardiovascular and cerebrovascular diseases. Preclinical atherosclerosis is the sub-clinical stage of atherosclerosis. Under the guidance of blood turbidity theory, treating the preclinical atherosclerosis can reduce the incidence of acute cardiovascular and cerebrovascular events. It is also the embodiment of the idea of prevention of diseases in traditional Chinese medicine, which is of great significance for the primary prevention of diseases. |
| Key words: blood turbidity theory preclinical atherosclerosis prevention of disease clearing blood turbidity |
